Please login to the form below

Not currently logged in
Email:
Password:

Repositive appoints scientific lead

Manuel Corpas joins the genome software company

Repositive Manuel CorpasCambridge, UK-based Repositive has appointed Manuel Corpas as its scientific lead.

In his new role, Corpas will be responsible for building awareness in the scientific community around Repositive's platform through workshops and key event presentations.

He joins the human genomic research data software developer from The Genome Analysis Centre, where he served as project leader for plant and animal genomes.

During this time, Corpas was also the board director for the International Society for Computational Biology and served as the ELIXIR-UK technical coordinator.

Prior to this, he held a number of roles at the European Bioinfomatics Institute, Sanger and the Spanish National Bioinformatics Centre.

Fiona Nielson, chief executive officer of Repositive, said: “Manny will be a great addition to the team, and is perfect for helping us increase awareness of Repositive in the scientific community.

“He has build an incredibly strong reputation for both innovate science and promoting the benefits of collaboration, and his experience and connections will be crucial in building Repositive as the go-to platform for human genomic data.”

6th September 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Red Health

Red Health was formed in 2007 to bring something fresh to the healthcare PR world. Our approach was simple –...

Latest intelligence

Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...
Generation Z
The roaring ‘20s and Generation Z
How a new generation will shape pharma comms this decade...

Infographics